Bernstein CN, Blanchard JF, Kliewer E, Wajda A: Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001, 91: 854-862. 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z.
Article
CAS
PubMed
Google Scholar
Greenstein AJ: Cancer in inflammatory bowel disease. Mt Sinai J Med. 2000, 67: 227-240.
CAS
PubMed
Google Scholar
Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN: Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994, 35: 1590-1592.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gillen CD, Andrews HA, Prior P, Allan RN: Crohn's disease and colorectal cancer. Gut. 1994, 35: 651-655.
Article
CAS
PubMed
PubMed Central
Google Scholar
Judge TA, Lewis JD, Lichtenstein GR: Colonic dysplasia and cancer in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2002, 12: 495-523. 10.1016/S1052-5157(02)00014-4.
Article
PubMed
Google Scholar
Rhodes JM, Campbell BJ: Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med. 2002, 8: 10-16. 10.1016/S1471-4914(01)02194-3.
Article
CAS
PubMed
Google Scholar
Viscido A, Bagnardi V, Sturniolo GC, Annese V, Frieri G, D'Arienzo A, Papi C, Riegler G, Corrao G, Caprilli R: Survival and causes of death in Italian patients with ulcerative colitis. Dig Liver Dis. 2001, 33: 686-692. 10.1016/S1590-8658(01)80046-3.
Article
CAS
PubMed
Google Scholar
Hein DW: Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res. 2002, 506–507: 65-77.
Article
PubMed
Google Scholar
Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000, 9: 29-42.
CAS
PubMed
Google Scholar
Hein DW: Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta. 1988, 948: 37-66.
CAS
PubMed
Google Scholar
Stabbert R, Schafer KH, Biefel C, Rustemeier K: Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom. 2003, 17: 2125-2132. 10.1002/rcm.1161.
Article
CAS
PubMed
Google Scholar
Ye Z, Parry JM: Meta-analysis of 20 case-control studies on the Nacetyltransferase 2 acetylation status and colorectal cancer risk. Med Sci Monit. 2002, 8: CR558-CR565.
CAS
PubMed
Google Scholar
Farmer M, Petras RE, Hunt LE, Janosky JE, Galandiuk S: The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol. 2000, 95: 3184-3188. 10.1111/j.1572-0241.2000.03199.x.
Article
CAS
PubMed
Google Scholar
Melville DM, Jass JR, Morson BC, Pollock DJ, Richman PI, Shepherd NA, Ritchie JK, Love SB, Lennard-Jones JE: Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol. 1989, 20: 1008-1014. 10.1016/0046-8177(89)90273-6.
Article
CAS
PubMed
Google Scholar
Odze RD, Goldblum J, Noffsinger A, Alsaigh N, Rybicki LA, Fogt F: Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol. 2002, 15: 379-386. 10.1038/modpathol.3880534.
Article
PubMed
Google Scholar
Doll MA, Hein DW: Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. Anal Biochem. 2001, 288: 106-108. 10.1006/abio.2000.4892.
Article
CAS
PubMed
Google Scholar
Doll MA, Hein DW: Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1. Anal Biochem. 2002, 301: 328-332. 10.1006/abio.2001.5520.
Article
CAS
PubMed
Google Scholar
Hein DW: N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene. 2006, 25: 1649-1658. 10.1038/sj.onc.1209374.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K: Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant human wild-type, mutant, and chimeric NAT2 allozymes. Human Molecular Genetics. 1994, 3: 729-734. 10.1093/hmg/3.5.729.
Article
CAS
PubMed
Google Scholar
Benjamini Y, Hochberg Y: Controlling the False Discovery Rate : a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. 1995, 57: 290-300.
Google Scholar
SAS Institute Inc. 100 Campus Drive Cary, NC 27513-2414 USA.
Ilett KF, David BM, Detchon P, Castleden WM, Kwa R: Acetylation phenotype in colorectal carcinoma. Cancer Res. 1987, 47: 1466-1469.
CAS
PubMed
Google Scholar
Forehand JB, Dooly GL, Moldoveanu SC: Analysis of polycyclic aromatic hydrocarbons, phenols and aromatic amines in particulate phase cigarette smoke using simultaneous distillation and extraction as a sole sample clean-up step. J Chromatogr A. 2000, 898: 111-124. 10.1016/S0021-9673(00)00827-X.
Article
CAS
PubMed
Google Scholar
Wohlleb JC, Hunter CF, Blass B, Kadlubar FF, Chu DZ, Lang NP: Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int J Cancer. 1990, 46: 22-30. 10.1002/ijc.2910460107.
Article
CAS
PubMed
Google Scholar
Lang NP, Chu DZ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF: Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg. 1986, 121: 1259-1261. 10.1001/archsurg.121.11.1259.
Article
CAS
PubMed
Google Scholar
Hubbard AL, Harrison DJ, Moyes C, Wyllie AH, Cunningham C, Mannion E, Smith CA: N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut. 1997, 41: 229-234.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ricart E, Taylor WR, Loftus EV, O'Kane D, Weinshilboum RM, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ: N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis. Am J Gastroenterol. 2002, 97: 1763-1768. 10.1111/j.1572-0241.2002.05838.x.
Article
CAS
PubMed
Google Scholar
Tanigawara Y, Kita T, Aoyama N, Gobara M, Komada F, Sakai T, Kasuga M, Hatanaka H, Sakaeda T, Okumura K: N-acetyltransferase 2 genotype-related sulfapyridine acetylation and its adverse events. Biol Pharm Bull. 2002, 25 (8): 1058-62. 10.1248/bpb.25.1058.
Article
CAS
PubMed
Google Scholar
Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001, 48 (4): 526-35. 10.1136/gut.48.4.526.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, Lofberg R: Colorectal cancer in Ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1998, 29 (2): 206-217.
Article
Google Scholar
Moum B, Ekbom A: Ulcerative colitis, colorectal cancer and colonoscopic surveillance. Scand J Gastroenterol. 2005, 40 (8): 881-5. 10.1080/00365520510023701.
Article
PubMed
Google Scholar
Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, Takeshima F, Murase K, Matsumoto N, Murata I, Kohno S, Wen CY: Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol. 2005, 11: 4833-4837.
Article
CAS
PubMed
PubMed Central
Google Scholar